Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lipidor | LIPI | May 15, 2024 | 0.23 | +4.44 |
Lipigon Pharmaceuticals | LPGO | May 15, 2024 | 0.29 | 0.00 |
Lipum | LIPUM | May 15, 2024 | 6.70 | -2.19 |
Lumito | LUMITO | May 15, 2024 | 1.20 | +0.84 |
Magle Chemoswed | MAGLE | May 15, 2024 | 32.40 | 0.00 |
Medivir | MVIR | May 15, 2024 | 2.92 | +0.34 |
Mendus AB | IMMU | May 15, 2024 | 0.45 | -4.89 |
Miris Holding | MIR | May 15, 2024 | 0.16 | -4.32 |
Moberg Pharma | MOB | May 15, 2024 | 26.42 | -5.78 |
Modus Therapeutics | MODTX | May 15, 2024 | 1.01 | -1.46 |
Nanexa | NANEXA | May 15, 2024 | 0.92 | +9.03 |
Nanologica | NICA | May 15, 2024 | 6.08 | +2.70 |
NextCell Pharma AB | NXTCL | May 15, 2024 | 1.20 | -1.23 |
Nykode Therapeutics | NYKDO | May 15, 2024 | 13.05 | 0.00 |
ODI Pharma | ODI | May 15, 2024 | 7.60 | -1.30 |
Oncopeptides | ONCO | May 15, 2024 | 2.88 | -12.08 |
OncoZenge | ONCOZ | May 15, 2024 | 3.79 | -0.39 |
OptiCept Technologies | OPTI | May 15, 2024 | 2.17 | +0.93 |
Orexo | ORX | May 15, 2024 | 19.80 | +1.54 |
OssDsign | OSSD | May 15, 2024 | 9.50 | -1.45 |
Peptonic Medical | PMED | May 15, 2024 | 0.01 | +6.45 |
PharmaLundensis | PHAL | May 15, 2024 | 0.57 | 0.00 |
Pila Pharma | PILA | May 15, 2024 | 2.44 | 0.00 |
Polymer Factory Sweden | POLYMER | May 15, 2024 | 0.69 | -4.79 |
Probi | PROB | May 15, 2024 | 210.00 | -1.87 |
Promimic AB | PRO | May 15, 2024 | 26.30 | -0.75 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | May 15, 2024 | 0.07 | +6.56 |
RaySearch Laboratories B | RAYB | May 15, 2024 | 123.40 | -6.52 |
Redwood Pharma | REDW | May 15, 2024 | 1.05 | -7.46 |
Respiratorius | RESP | May 15, 2024 | 0.24 | -3.60 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.